VNRX
VolitionRx (VNRX)
$39
About VolitionRx (VNRX)
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
Details
Daily high
$0.40
Daily low
$0.37
Price at open
$0.40
52 Week High
$0.94
52 Week Low
$0.37
Market cap
46.6M
Dividend yield
0.00%
Volume
482,624
Avg. volume
1.1M
P/E ratio
-1.60
VolitionRx News
Details
Daily high
$0.40
Daily low
$0.37
Price at open
$0.40
52 Week High
$0.94
52 Week Low
$0.37
Market cap
46.6M
Dividend yield
0.00%
Volume
482,624
Avg. volume
1.1M
P/E ratio
-1.60